Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (11)

2023

  1. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

2022

  1. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  2. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2018

  1. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review

    Clinical and experimental rheumatology, Vol. 36, Núm. 4, pp. 652-657

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2016

  1. Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain

    Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152

2013

  1. Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition

    BMC Medical Genetics, Vol. 14, Núm. 1

  2. Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis

    PLoS ONE, Vol. 8, Núm. 10

  3. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis

    Mediators of Inflammation, Vol. 2013

2012

  1. Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients

    Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581